Dexamethasone Use in Pediatric Heart Surgery and Its Effects on Inflammation
Author Information
Author(s): Lerzo Franco, Peri Giuseppe, Doni Andrea, Bocca Paola, Morandi Fabio, Pistorio Angela, Carleo Anna Maria, Mantovani Alberto, Pistoia Vito, Prigione Ignazia
Primary Institution: G. Gaslini Institute, IRCCS
Hypothesis
Does dexamethasone prophylaxis in pediatric patients undergoing cardiopulmonary bypass affect blood levels of inflammatory markers?
Conclusion
Dexamethasone prophylaxis is associated with increased blood levels of PTX3, which may help reduce inflammation and improve clinical outcomes.
Supporting Evidence
- Dexamethasone-treated patients had significantly higher PTX3 levels during surgery compared to untreated patients.
- CRP levels were significantly higher in untreated patients postoperatively.
- Fibrinogen and PTT values were also higher in untreated patients on the first postoperative day.
- IL-1RII levels increased in both groups but did not reach statistical significance.
Takeaway
Giving a medicine called dexamethasone to kids before heart surgery helps their bodies fight inflammation better.
Methodology
The study involved 29 children undergoing open heart surgery, with 14 receiving dexamethasone and 15 as controls, measuring various inflammatory markers at different time points.
Potential Biases
Potential biases may arise from the non-blinded nature of the study and the small sample size.
Limitations
The study's findings may not be generalizable due to the small sample size and specific patient criteria.
Participant Demographics
Children under 10 kg undergoing biventricular corrections, with a mix of genders.
Statistical Information
P-Value
0.0184, 0.0110, 0.0235, 0.0002, 0.0049, 0.0034
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website